Status:
COMPLETED
Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Prostatic Hyperplasia
Eligibility:
MALE
Brief Summary
Study to evaluate the safety profile of Secotex® in the improvement of the symptoms of Benign Prostatic Hyperplasia in real clinical practice
Eligibility Criteria
Inclusion
- Patients of any age with a diagnosis of symptomatic Benign Prostatic Hyperplasia (BPH)
- Patients with symptoms, that according to physician require medical treatment to improve quality of life
- Patients could be naive to treatment or could be on treatment with other drugs but have not responded adequately to treatment
Exclusion
- Patients with known hypersensitivity to Tamsulosin, or any other component of the product
- Patients with a history of orthostatic hypotension or severe liver failure
Key Trial Info
Start Date :
May 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
811 Patients enrolled
Trial Details
Trial ID
NCT02244346
Start Date
May 1 2004
Last Update
September 19 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.